T1	Participants 39 74	radiation therapy for breast cancer
T2	Participants 211 288	519 disease-free breast cancer patients 7 to 12 years after primary treatment
T3	Participants 290 433	All patients were treated in the context of a randomized trial where pre- and postoperative radiation (45 Gy) was evaluated versus surgery only
